The PI3K/AKT signalling pathway in inflammation, cell death and glial scar formation after traumatic spinal cord injury: Mechanisms and therapeutic opportunities

X He, Y Li, B Deng, A Lin, G Zhang, M Ma… - Cell …, 2022 - Wiley Online Library
Abstract Objects Traumatic spinal cord injury (TSCI) causes neurological dysfunction below
the injured segment of the spinal cord, which significantly impacts the quality of life in …

The fibroblast growth factor signaling pathway

DM Ornitz, N Itoh - Wiley Interdisciplinary Reviews …, 2015 - Wiley Online Library
The signaling component of the mammalian Fibroblast Growth Factor (FGF) family is
comprised of eighteen secreted proteins that interact with four signaling tyrosine kinase FGF …

[HTML][HTML] Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling …

F Wang, HQ Ying, BS He, YQ Pan, QW Deng, HL Sun… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been
recently shown to be dysregulated, which plays an important role in the progression of …

[HTML][HTML] FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis

M Katoh - International journal of molecular medicine, 2016 - spandidos-publications.com
Abstract Fibroblast growth factor (FGF) 2, FGF4, FGF7 and FGF20 are representative
paracrine FGFs binding to heparan-sulfate proteoglycan and fibroblast growth factor …

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma

RP Graham, EGB Fritcher, E Pestova, J Schulz… - Human pathology, 2014 - Elsevier
Patients with cholangiocarcinoma often present with locally advanced or metastatic disease.
There is a need for effective therapeutic strategies for advanced stage cholangiocarcinoma …

[HTML][HTML] Inventing new medicines: the FGF21 story

A Kharitonenkov, AC Adams - Molecular metabolism, 2014 - Elsevier
Since the discovery of insulin in 1921, protein therapeutics have become vital tools in the
treatment of diabetes mellitus. This heritage has been extended with the comparatively …

Recent advances in the development of indazole‐based anticancer agents

J Dong, Q Zhang, Z Wang, G Huang, S Li - ChemMedChem, 2018 - Wiley Online Library
Cancer is one of the leading causes of human mortality globally; therefore, intensive efforts
have been made to seek new active drugs with improved anticancer efficacy. Indazole …

[HTML][HTML] ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY

D Liu, T Zhang, X Chen, B Zhang, Y Wang, M Xie… - Cell Death & …, 2021 - nature.com
Metastasis is the predominant reason for high mortality of hepatocellular carcinoma (HCC)
patients. It is critical to explore the molecular mechanism underlying HCC metastasis. Here …

TAS‐120 cancer target binding: defining reactivity and revealing the first fibroblast growth factor receptor 1 (FGFR1) irreversible structure

M Kalyukina, Y Yosaatmadja, MJ Middleditch… - …, 2019 - Wiley Online Library
[(3S)‐3‐[4‐Amino‐3‐[2‐(3, 5‐dimethoxyphenyl) ethynyl]‐1H‐pyrazolo [3, 4‐d] pyrimidin‐1‐
yl]‐1‐pyrrolidinyl]‐2‐propen‐1‐one (TAS‐120) is an irreversible inhibitor of the fibroblast …

[HTML][HTML] Preclinical activity of ARQ 087, a novel inhibitor targeting FGFR dysregulation

TG Hall, Y Yu, S Eathiraj, Y Wang, RE Savage… - PLoS …, 2016 - journals.plos.org
Dysregulation of Fibroblast Growth Factor Receptor (FGFR) signaling through amplifications,
mutations, and gene fusions has been implicated in a broad array of cancers (eg liver …